FEMALE SEXUAL DYSFUNCTION
Abstract
Female sexual dysfunction affect up to 43% of women causing a "distress" or a psychological strain for the patients. A variety of chronic diseases in addition to menopause and different drugs represents the risk factors to a female sexual dysfunction. Since 2015 the FDA has approved Flibanserin for the treatment of female libido although several other drugs have been proven efficacious.

About the Authors
C. DADAKAustria
University Clinic of obstetrics and gynecology Center for teaching
M. BAYERLE-EDE
Austria
Medical University of Vienna Department of internal medicine III, Department of Endocrinology and metabolism
For citation:
DADAK C., BAYERLE-EDE M. FEMALE SEXUAL DYSFUNCTION. Obstetrics, Gynecology and Reproduction. 2015;9(4):86-88. (In Russ.) https://doi.org/10.17749/2070-4968.2015.9.4.086-088

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.